Effects of homocysteine lowering with B vitamins on cognitive aging: Meta-analysis of 11 trials with cognitive data on 22,000 individuals

American Journal of Clinical Nutrition

Volumn 100, Issue 2, 2014, Pages 657-666

  Clarke, Robert ^a   Bennett, Derrick ^a   Parish, Sarah ^a   Lewington, Sarah ^a   Skeaff, Murray ^b   Eussen, Simone J P M ^c,d   Lewerin, Catharina ^e   Stott, David J ^f   Armitage, Jane ^a   Hankey, Graeme J ^g   Lonn, Eva ^h   Spence, J David ⁱ   Galan, Pilar ^j,k,l,m   De Groot, Lisette C ⁿ   Halsey, Jim ^a   Dangour, Alan D ^o   Collins, Rory ^a   Grodstein, Francine ^p  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF BERGEN   (Norway)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ UNIVERSITY OF WESTERN ONTARIO   (Canada)

^j INSERM   (France)

^k Inra U1125 ^*  (France)

^l Bioinformatique et Chimie Moléculaire   (France)

^m UNIVERSITÉ PARIS 13   (France)

ⁿ WAGENINGEN UNIVERSITY   (Netherlands)

^o LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^p BRIGHAM AND WOMEN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; VITAMIN B COMPLEX;

AGED; AGING; ANTAGONISTS AND INHIBITORS; BLOOD; COGNITION; DIET THERAPY; DIETARY SUPPLEMENT; EVIDENCE BASED MEDICINE; HUMAN; HYPERHOMOCYSTEINEMIA; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; COGNITION; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN B COMPLEX;

EID: 84904872696     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.113.076349     Document Type: Article

References (41)

1. Mayeux R. Early Alzehimer's disease. N Engl J Med 2010;362:2194-201.
2. Clarke R, Smith AD, Jobst K, Sutton L, Refsum H, Ueland PM. Plasma homocysteine, folate and vitamin B-12 as risk factors for confirmed Alzheimer's disease. Arch Neurol 1998;55:1449-55.
3. Clarke R. B-vitamins and prevention of dementia. Proc Nutr Soc 2008;67:75-81.
4. Clarke R, Birks J, Nexo E, Ueland PM, Schneede PM, Scott J, Molloy A, Frost C, Evans JM. Low vitamin B12 status and risk of cognitive decline in older people. Am J Clin Nutr 2007;86:1384-91.
5. Seshadri S, Beiser A, Selhub J, Jacques P, D'Agostino RB, Wilson PW, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-83.
6. Kivipelto M, Annerbo S, Hultin J, Backman L, Viitanen M, Fratiglioni L, Lokk J. Homocysteine and transcobalamin and the risk of dementia and Alzheimer's disease: a prospective study. Eur J Neurol 2009;16:808-13.
7. Eussen SJ, de Groot LC, Joosten LW, Bloo RJ, Clarke R, Ueland PM, Schneede J, Blom HJ, Hoefnagels WH, van Staveren WA. Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebocontrolled trial. Am J Clin Nutr 2006;84:361-70.
8. Lewerin C, Matousek M, Steen G, Nilsson-Ehle H. Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study. Am J Clin Nutr 2005;81:1155-62.
9. McMahon JA, Green TJ, Skeaff M, Knight RF, Mann JL, Williams SM. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 2006;354:2764-72.
10. Durga J, van Boxtel MP, Schouten EG, Kok FJ, Jolles J, Katan MB, Verhoef P. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 2007;369:208-16.
11. Stott DJ, MacIntosh G, Lowe GDO, Rumley A, McMahon AD, Langhorne P, Tait RC, Spilg EG, MacDonald JB, MacFarlane PW, et al. Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease. Am J Clin Nutr 2005;82:1320-6.
12. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, Sheridan P, Pogue J, Micks M, McQueen MJ, et al. Homocysteine lowering with folic acid and B-vitamins in vascular disease. N Engl J Med 2006;354:1567-77.
13. Andreeva VA, Kesse-Guyot E, Barberger-Gateau P, Fezeu L, Hercberg S, Galan P. Cognitive function following supplementation with B-vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU. FOL. OM3 randomized trial. Am J Clin Nutr 2011;94:278-86.
14. Kang JH, Cook N, Manson JE, Buring JE, Albert CM, Grodstein F. A trial of B-vitamins and cognitive function in women at high risk of cardiovascular disease. Am J Clin Nutr 2008;88:1602-10.
15. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004;291:565.75.
16. VITATOPS Trial Study Group. B-vitamins in patients with recent ischaemic attack or stroke in the B-vitamins to prevent stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol 2010;9:855.65.
17. Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group. Effects of homocysteinelowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA 2010;24:2486.94.
18. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189.98.
19. Brandt J, Spencer M, Folstein MF. The telephone Interview for cognitive status. Neuropsych Neuropsychol Behav Neurol 1988;1:111.7.
20. Buckwalter JG, Crooks VC, Petitti DB. A preliminary psychometric analysis of a computer-assisted administration of the Telephone Interview of Cognitive Status modified. J Clin Exp Neuropsychol 2002;24:168.75.
21. de Jager CA, Budge MM, Clarke R. Utility of TICS-M for the assessment of cognitive function in older adults. Int J Geriatr Psychiatry 2003;18:318.24.
22. Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, Manson JE, Bønaa KH, Spence JD, Nygård O, Jamison R, et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37485 individuals. Arch Intern Med 2010;170:1622.31.
23. Armitage P, Berry G. Statistical methods in medical research. Oxford, United Kingdom: Blackwell Scientific Publications, 1994.
24. Wald DS, Kasturiratne A, Simmonds M. Effect of folic acid, with or without other B-vitamins, on cognitive decline: meta-analysis of randomized trials. Am J Med 2010;123:522.7.
25. Ford AH, Almeida OP. Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials. J Alzheimers Dis 2012;29:133.49.
26. Norman GR. Issues in the use of change scores in randomized trials. J Clin Epidemiol 1989;42:1097.105.
27. da Costa BR, Nuesch E, Ruties AW, Johnston BC, Reichenbach S, Trelle S, Guyatt GH, Juni P. Combining follow-up and change data is valid in meta-analyses of continuous outcomes: a meta-epidemiological study. J Clin Epidemiol 2013;66:847.55.
28. Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, et al. Highdose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA 2008;300:1774.83.
29. Walker JG, Batterham PJ, Mackinnon AJ, Jorm AF, Hickie I, Fenech M, Kljakovic M, Crisp D, Christensen H. Oral folic acid and vitamin B-12 supplementation to prevent cognitive decline in communitydwelling older adults with depressive symptoms. the Beyond Ageing Project: a randomized controlled trial. Am J Clin Nutr 2012;95:194. 203.
30. (Published erratum appears in Am J Clin Nutr 2012;96(2):448.)
31. de Jager CA, Oulhaj A, Jacoby R, Refsum H, Smith AD. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int J Geriatr Psychiatry 2012;27:592. 600.
32. Ford AH, Flicker L, Alfonso H, Thomas J, Clarnette R, Martins R, Almeida OP. Vitamins B (12), B (6), and folic acid for cognition in older men. Neurology 2010;75:1540. 7.
33. (Published erratum appears in Neurology 2011;77(8):804.)
34. Vollset SE, Clarke R, Lewington S, Ebbing M, Halsey J, Lonn E, Armitage J, Manson JE, Hankey GJ, Spence JD, et al. Effects of folic acid on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50 000 individuals. Lancet 2013;381:1029.36.
35. Spence JD. Homocysteine-lowering therapy: a role in stroke prevention? Lancet Neurol 2007;6:830. 8.
36. Radimer K, Bindewald B, Hughes EB, Swanson C, Picciano MF. Dietary supplement use by US adults: data from the National Nutrition Survey 1999-2000. Am J Epidemiol 2004;160:339.49.
37. Henderson L, Gregory J, Swan G. The National Diet and Nutrition Survey: adults aged 19 to 64 years, types and quantities of food consumed. London, United Kingdom: HMSO, 2003.
38. Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, Oulhaj A, Bradley KM, Jacoby R, Refsum H. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized trial. PLoS ONE 2010;5:e12244.
39. Douaud G, Refsum H, deJager CA, Jacoby R, Nichols TE, Smith SE, Smith AD. Preventing Alzheimer's disease-related grey matter atrophy by B-vitamin treatment. Proc Natl Acad Sci USA 2013;110:9523.8.
40. Clarke R, Bennett D, Parish S, Verhoef P, Dötsch-Klerk M, Lathrop M, Xu P, Nordestgaard BG, Holm H, Hopewell JC, et al. Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. PLoS Med 2012;9:e1001177.
41. Grarup N, Sulem P, Sandholt CH, Thorleifsson G, Ahluwalia TS, Steinthorsdottir V, Bjarnason H, Gudbjartsson D, Magnusson O, Sparsø T, et al. Genetic architecture of vitamin B12 and folate levels uncovered applying deeply sequenced large datasets. PLoS Genet 2013;9:e1003530